MEtformin and Lorcaserin for WeighT Loss in Schizophrenia

Stopped The FDA advised of a possible health risk associated with lorcaserin and the drug is being withdrawn.

Conditions

• Schizophrenia
• Schizoaffective Disorder
• Overweight

Interventions

• DRUG: Lorcaserin
• DRUG: Metformin
• DRUG: Placebo

Sponsor

University of North Carolina, Chapel Hill

Collaborators

• [object Object]
• [object Object]